LUNG THERAPEUTICS, INC. sold 24.2% of their position (715K shares) of TFF PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $10.01M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/30/2021ACC: 0001213900-21-018561
10% Owner
Since Oct 2019
-715K
Net shares
Net seller
$10.01M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
715K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−715K
Price / share
$14.00
Trade value
$10.01M
% of position
24.2%
3/26/2021
2.95M→2.23M
Total
Net shares
−715K
Net value
-$10.01M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/26/2021 | S · Sale | −715K | $14.00 | $10.01M | 24.2% | 2.95M | 2.23M |
| Total | −715K | -$10.01M | ||||||
Derivative Transactions0
No derivative transactions reported